Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Drug Insight: an overview of current anticoagulation therapy after heart valve replacement
2005
Myasthenia Gravis
2016 Standout
Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement
2005
Operation for Infective Endocarditis: Results After Implantation of Mechanical Valves
1998
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
2005 Standout
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
1998
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
2021
Long-term results of valve replacement with the St. Jude Medical prosthesis
1995
4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest
2007
Unresolved issues in anticoagulant therapy
2003
Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function
2011
Pulmonary Embolectomy for Acute Massive Pulmonary Embolism
2005
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
2001
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Overlooked non-motor symptoms in myasthenia gravis
2012
Increased preoperative C-reactive protein plasma levels as a risk factor for postoperative infections
1999
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
2005
Paraneoplastic myasthenia gravis: immunological and clinical aspects
2008
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy
2007
Fulminant pulmonary embolism: Symptoms, diagnostics, operative technique, and results
1991
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Bacteriological Outcome after Valve Surgery for Active Infective Endocarditis: Implications for Duration of Treatment after Surgery
2005
Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study†
2013
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
2010
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
On the mechanisms of biocompatibility
2008 Standout
The biology and therapy of adult acute lymphoblastic leukemia
2003
Human myocardial adenosine triphosphatase activities in health and heart failure
1988
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia
1999
Nocardia Bacteremia: Report of 4 Cases and Review of the Literature
1998
Hypothermic circulatory arrest is not a risk factor for neurologic morbidity in aortic surgery: A propensity score analysis
2005
Infective endocarditis
2004 Standout
Outcome of Pulmonary Embolectomy
2006
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Pharmacological Management of Intermittent Claudication
2000
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Effects of anaesthesia and surgery on the immune response
1992
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
2011
Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases
2020
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Patient mortality in the 12 years following enrolment into a pre-surgical cardiac rehabilitation programme
2011
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery
2002
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
HNE Michael Adducts to Histidine and Histidine-Containing Peptides as Biomarkers of Lipid-Derived Carbonyl Stress in Urines: LC−MS/MS Profiling in Zucker Obese Rats
2007
Part 9: Post–Cardiac Arrest Care
2010 Standout
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
The Role of Thymomas in the Development of Myasthenia Gravis
2003
Acute Pulmonary Thromboembolism Treated Successfully by Balloon Angioplasty—A Case Report
1988
Cancer treatment and survivorship statistics, 2016
2016 Standout
Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)
2007
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas
2007
Burn Wound Infections
2006 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
The Mononuclear Molybdenum Enzymes
2014 Standout
Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5)
2001
Psychosocial interventions for smoking cessation in patients with coronary heart disease
2015
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Economic analysis of bleeding and thromboembolic sequelae after heart valve replacement (GELIA 7)
2001
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis
1994
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of O. Elert being referenced
[Effectiveness of Dusodril-Pi in arterial occlusive diseases. A multicentric double-blind study].
1979
Early and Late Prognosis Following Valve Replacement for Bacterial Endocarditis of the Native Valve
1995
Selective loss of regulatory T cells in thymomas
2004
Nocardial endocarditis after aortic valve replacement: Reports of Two Cases
1988
Entwicklung kardiovaskulärer Risikofaktoren bei Patienten nach aortokoronarer Bypassoperation und einem Frührehabilitationsprogramm (Phase I der Rehabilitation nach WHO): 1-Jahres-Follow-up
2006
Formation of 4-Hydroxy-2-Nonenal Protein Adducts in the Ischemic Rat Heart After Transplantation
2005
Cerebral oxygen saturation assessed by near-infrared spectroscopy during coronary artery bypass grafting and early postoperative cognitive function
2002
Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting
1996
Aortic Bioprosthesis Without Early Anticoagulation-Risk of Thromboembolism
1995
Influence of different autotransfusion devices on the quality of salvaged blood
1999
The effectiveness of a motivation programme for lifestyle change in the course of aortocoronary bypass graft surgery
2007
Surgical management of massive pulmonary embolism
1978
German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
1993
Electron microscopic visible ischemic changes of the mitochondrial ATPases in human myocardial cells during extracorporal circulation
1981
Predictive value of skin testing, neutrophil migration and C‐reactive protein for postoperative infections in cardiopulmonary bypass patients
1987
Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas
2002